Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

ClinicalTrials.gov ID: NCT01290341

Public ClinicalTrials.gov record NCT01290341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Study identification

NCT ID
NCT01290341
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merz North America, Inc.
Industry
Enrollment
860 participants

Conditions and interventions

Conditions

Interventions

  • NAFT-600 (naftin 2 % gel) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Oct 31, 2011
Completion
Nov 30, 2011
Last update posted
Sep 25, 2013

2011

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Radiant Research, Inc. Tucson Arizona 85710
T. Joseph Raoof, MD, Inc. Encino California 91436
Walter K. Nahm, MD, PhD, Inc. San Diego California 92123
Colorado Medical Research Center Denver Colorado 80210
Longmont Clinic, PC Longmont Colorado 80501
Tampa Bay Medical Research Clearwater Florida 33761
Lake Washington Foot and Ankle Center Melbourne Florida 32935
Clinical Research Atlanta Stockbridge Georgia 30281
Hudson Dermatology Evansville Indiana 47714
Department of Veterans Affairs Minneapolis Minnesota 55417
Academic Dermatology Associates Albuquerque New Mexico 87106
Radiant Research, Inc Cincinnati Ohio 45249
Radiant Research, Inc. Columbus Ohio 43212
Oregon Dermatology & Research Center Portland Oregon 97210
Temple University- School of Podiatric Medicine Philadelphia Pennsylvania 19107
Palmetto Clinical Trial Services, LLC Simpsonville South Carolina 29681
DermResearch, Inc. Austin Texas 78759
J&S Studies, Inc. College Station Texas 77845
Research Across America Dallas Texas 75234
Endeavor Clinical Trials, PA San Antonio Texas 78229
Progressive Clinical Research San Antonio Texas 78229
The Education and Research Foundation, Inc. Lynchburg Virginia 24501
Madison Skin and Research, Inc Madison Wisconsin 53719

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01290341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01290341 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →